Status:
COMPLETED
Barley Beta-glucan, Glycemic Control, and Appetite
Lead Sponsor:
Washington State University
Conditions:
Diet, Healthy
Blood Sugar; High
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
Novel barley varieties high in the soluble fiber β-glucan have the capacity to improve population health through improving glycemic control. Sweetened and unsweetened wholegrain barley foods were test...
Eligibility Criteria
Inclusion
- 18-50 years of age
- Body Mass Index (BMI) values of 18.5-40.0 kg/m2
- Normal fasting blood glucose (\<100 mg/dL)
Exclusion
- Use of medications known to be associated with weight change (e.g., beta-blockers)
- Use of steroid pills or shots such as prednisone or cortisone
- Use of nicotine
- Weight change of ten or more pounds in the last three months
- Major daily variation in physical activity (e.g., athletes in training)
- History of extensive small bowel surgery or surgery to treat obesity
- History of heart attack, stroke, or bypass
- History of cancer within the last five years (exception: non-melanoma skin cancer)
- Recent or current medical diagnosis or medical treatment that would alter appetite, energy needs, satiety, and/or could impact the results of the trial
- Medical diagnoses of diabetes, cardiovascular disease, high levels of blood lipids, asthma, cold, and flu (exception: hypertension, if treated with medication prescribed more than three months prior to the screening activity)
- Fear of blood or needles
- Dietary restrictions that would interfere with consuming test foods (e.g., gluten intolerance, vegan, corn syrup allergy)
- Following a weight modification diet
- Sensitive to food textures present in the test foods
- Following personal schedules that would not permit attendance at all scheduled testing sessions
- Unable to comprehend the nature of the trial or instructions
- Unable to understand English sufficiently to complete the trial
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2020
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT06146322
Start Date
October 1 2019
End Date
October 31 2020
Last Update
November 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington State University
Spokane, Washington, United States, 99202